# Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels

Study · id `cardio:ct-nct06345209` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06345209](<https://clinicaltrials.gov/study/NCT06345209>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06345209

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 236 participants.

## Technical summary

Registry record NCT06345209. Randomized; double masking; primary purpose treatment. Start 2024-05 (anticipated); primary completion 2024-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 236 participants (planned count; ClinicalTrials.gov record NCT06345209, source copy `cardio:ctgov-nct06345209-2024-04-03`, retrieved 2026-10-26)
- Planned start: 2024-05 (anticipated) (ClinicalTrials.gov record NCT06345209, source copy `cardio:ctgov-nct06345209-2024-04-03`, retrieved 2026-10-26)
- Primary completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT06345209, source copy `cardio:ctgov-nct06345209-2024-04-03`, retrieved 2026-10-26)
- Completion: 2025-12 (anticipated) (ClinicalTrials.gov record NCT06345209, source copy `cardio:ctgov-nct06345209-2024-04-03`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06345209-2024-04-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels
- Condition: Coronary Artery Disease
- Intervention (Device): Sirolimus-coated Coronary Balloon Dilatation Catheter
- Intervention (Device): Drug-coated Coronary Balloon Dilatation Catheter
- Lead sponsor: BrosMed Medical Co., Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: BrosMed Medical Co., Ltd (`cardio:org-brosmed-medical-co-ltd`)
- Registry lists this organization as a collaborator: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)

## Provenance

Content hash: 6ad168efe7ea9a98556c6a061f3632895fe7b48115b16618ef5f184f494709fe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
